Concepedia

Ann E. Bolton

AE

4

Publications

5K

Citations

4

H-Index

2003

Active since

Affiliations

Novartis (Switzerland)(Current)

Heidelberg University

Novartis (United States)

Hammersmith Hospital

Ann E. Bolton is an author at Novartis (Switzerland) specializing in clinical pharmacology, drug resistance, and pharmacotherapy.

Top concepts

Publications per year

2003–2005

4

Publications

4

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Stephen G. O’Brien, François Guilhot, Richard A. Larson et al. · New England Journal of Medicine · 2003 · 3.5K citations · Full text

Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid Leukemia

Timothy P. Hughes, Jaspal Kaeda, Susan Branford et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text

Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects

Ann E. Bolton, Bin Peng, Martine Hubert et al. · Cancer Chemotherapy and Pharmacology · 2004 · 156 citations

, , +6

Population pharmacokinetics of imatinib mesylate in patients with chronic‐phase chronic myeloid leukaemia: results of a phase III study

Heinz Schmidli, Bin Peng, G‐J. Riviere et al. · British Journal of Clinical Pharmacology · 2005 · 124 citations · Full text

Rows per page

1–4 of 4